(17/05/2023)vs COBALT | 40 | 7 | 1 / 250% | 0 / 40% | 2 / 825% | 2 / 1216.7% | | 1 | 4 | 0 | 4 | 4 | 3 | 0 | 2 | 5 |
(25/04/2023)vs TSAFOSHOME | 40 | 12 | 1 / 250% | 1 / 616.7% | 3 / 1030% | 4 / 1625% | | 2 | 10 | 4 | 14 | 6 | 1 | 0 | 1 | 19 |
(21/03/2023)vs Σ.Ε.Ε.Τ.Τ. | 27 | 2 | 2 / 2100% | 0 / 20% | 0 / 70% | 0 / 90% | | 1 | 2 | 0 | 2 | 2 | 0 | 0 | 0 | -3 |
(20/02/2023)vs Ο.Σ.Υ.Ε. - Κ.Ε.Ε.Ε. | 19 | 2 | 0 / 00% | 1 / 425% | 0 / 40% | 1 / 812.5% | | 1 | 2 | 0 | 2 | 0 | 2 | 0 | 2 | -3 |
(24/01/2023)vs ΙΑΤΡΙΚΟ ΚΕΝΤΡΟ BC | 23 | 4 | 0 / 30% | 2 / 922.2% | 0 / 30% | 2 / 1216.7% | | 1 | 1 | 1 | 2 | 2 | 2 | 0 | 0 | -3 |
(17/01/2023)vs Σ.Ε.ΕΑΒ | 22 | 7 | 0 / 00% | 2 / 540% | 1 / 425% | 3 / 933.3% | | 1 | 7 | 0 | 7 | 2 | 2 | 0 | 1 | 11 |
(21/12/2022)vs Σ.Ε.Ε.Τ.Τ. | 22 | 7 | 1 / 1100% | 3 / 560% | 0 / 10% | 3 / 650% | | 0 | 3 | 0 | 3 | 2 | 1 | 0 | 4 | 6 |
(06/12/2022)vs PHARMACIA | 21 | 7 | 0 / 00% | 2 / 540% | 1 / 520% | 3 / 1030% | | 0 | 4 | 0 | 4 | 3 | 2 | 0 | 0 | 9 |
(01/12/2022)vs Ο.Σ.Υ.Ε. - Κ.Ε.Ε.Ε. | 06 | 3 | 0 / 00% | 0 / 00% | 1 / 1100% | 1 / 1100% | | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 4 |
(01/11/2022)vs ΙΑΤΡΙΚΟ ΚΕΝΤΡΟ BC | 13 | 5 | 0 / 00% | 1 / 250% | 1 / 520% | 2 / 728.6% | | 1 | 1 | 1 | 2 | 0 | 3 | 0 | 1 | 4 |
ΣΥΝΟΛΙΚΑ |
233 |
56 |
5 / 1050% |
12 / 4228.6% |
9 / 4818.8% |
21 / 9023.3% |
|
8 |
34 |
6 |
40 |
21 |
17 |
0 |
11 |
49 |
ΜΕΣΟΙ ΟΡΟΙ |
23.3 |
5.6 |
0.5 / 150% |
1.2 / 4.228.6% |
0.9 / 4.818.8% |
2.1 / 923.3% |
|
0.8 |
3.4 |
0.6 |
4 |
2.1 |
1.7 |
0 |
1.1 |
4.9 |